FactMR: Treatment-Resistance Depression Treatment Making Advances: Study
Initiatives undertaken to spread awareness on mental health will fuel demand for treatment-resistance depression treatment
NEW YORK, NY / ACCESSWIRE / March 10, 2021 / Market research firm Fact.MR ongoing study presents bullish outlook on the treatment-resistance depression treatment market. As per the World Health Organization s (WHO s) factsheet, more than 264 million people worldwide of various age groups suffer from depression. Coupled with this, the prevalence of treatment-resistant depression is peaking, especially in America and several countries across Europe.
Treatment-resistant depression (TRD) continues to be one of the highly neglected public health issue. A BMC Psychiatry study has found that treatment resistance is common among patients identified with major depressive disorders. Against this backdrop, the demand for treatment-resistance depression treatment is poised to surge.
Autoimmune Disease Treatment Opportunities Provide Impetus to Pegfilgrastim Biosimilar Market: Fact MR Study
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
Treatment-Resistance Depression Treatment Making Advances: Study
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.